[Current problems in medical virology. VI. Virostatics--what we need and what we have].
D000212:Acyclovir; D000547:Amantadine / Q000627:therapeutic use; D000577:Amides; D000998:Antiviral Agents / Q000627:therapeutic use*; D019791:Guanidine; D006146:Guanidines / Q000627:therapeutic use; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D007372:Interferons / Q000502:physiology*; D008720:Methisazone / Q000031:analogs & derivatives / Q000627:therapeutic use; D010746:Phosphonoacetic Acid / Q000627:therapeutic use; D011720:Pyrazoles; D011743:Pyrimidines / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use; D012266:Ribose; D013936:Thymidine / Q000031:analogs & derivatives; D014740:Vidarabine / Q000627:therapeutic use; D014777:Virus Diseases / Q000628:therapy*
D000577:Amides; D000998:Antiviral Agents; D006146:Guanidines; D011720:Pyrazoles; D011743:Pyrimidines; D012263:Ribonucleosides; C002997:pyrazofurin; D006147:Guanine; C022832:N-methylisatin beta-4',4'-diethylthiosemicarbazone; D012266:Ribose; D007372:Interferons; D000547:Amantadine; D014740:Vidarabine; D019791:Guanidine; D008720:Methisazone; D010746:Phosphonoacetic Acid; D013936:Thymidine; D000212:Acyclovir
Aktuelle Probleme der medizinischen Virologie. VI. Virostatika--Soll und Haben.